InvestSMART

Australian Pharmaceutical Industries Limited (ASX: API) - Announcements

DELISTED - Current share price for API : $1.530

ASX company news and announcements for Australian Pharmaceutical Industries Limited (API) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Pharmaceutical Industries Limited (API) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Pharmaceutical Industries Limited (API), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Pharmaceutical Industries Limited (API)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Ceasing to be a substantial holder from CBA 23 Mar 2021 2:57PM $1.300 $1.530 risen by 17.69%
- Change of Director's Interest Notice 4 Feb 2021 10:38AM $1.275 $1.530 risen by 20%
- Appendix 3G 4 Feb 2021 10:36AM $1.275 $1.530 risen by 20%
- 2020 AGM - Results of Meeting 20 Jan 2021 4:11PM $1.235 $1.530 risen by 23.89%
- 2020 AGM- CEO & Managing Director Address to Shareholders 20 Jan 2021 1:37PM $1.225 $1.530 risen by 24.90%
- 2020 AGM- Chair's Address to Shareholders 20 Jan 2021 1:34PM $1.225 $1.530 risen by 24.90%
- 2020 AGM- Presentation to Shareholders 20 Jan 2021 1:28PM $1.225 $1.530 risen by 24.90%
- API- 2020 AGM Arrangements 14 Jan 2021 11:23AM $1.205 $1.530 risen by 26.97%
- Further Supplement to Notice of 2020 Annual General Meeting 8 Jan 2021 9:02AM $1.270 $1.530 risen by 20.47%
- Appendix 3G 7 Jan 2021 1:53PM $1.260 $1.530 risen by 21.43%
- Change in substantial holding from MUFG 29 Dec 2020 3:44PM $1.270 $1.530 risen by 20.47%
- Supplement to Notice of Annual General Meeting 23 Dec 2020 8:25AM $1.240 $1.530 risen by 23.39%
- Change of Director's Interest Notice 16 Dec 2020 12:08PM $1.285 $1.530 risen by 19.07%
- Letter to Shareholders - Final Dividend Payment 15 Dec 2020 8:21AM $1.290 $1.530 risen by 18.60%
- Appendix 4G - Key to Disclosures 15 Dec 2020 8:20AM $1.290 $1.530 risen by 18.60%
- API 2020 Corporate Governance Statement 15 Dec 2020 8:20AM $1.290 $1.530 risen by 18.60%
- Proxy Form - 2020 Annual General Meeting 15 Dec 2020 8:20AM $1.290 $1.530 risen by 18.60%
- Notice of 2020 Annual General Meeting 15 Dec 2020 8:20AM $1.290 $1.530 risen by 18.60%
- 2020 Annual Report 15 Dec 2020 8:20AM $1.290 $1.530 risen by 18.60%
- Letter to Shareholders - 2020 Annual General Meeting 15 Dec 2020 8:19AM $1.290 $1.530 risen by 18.60%
- Initial Director's Interest Notice 8 Dec 2020 11:36AM $1.230 $1.530 risen by 24.39%
- API Chair and new Director 4 Dec 2020 6:33PM $1.200 $1.530 risen by 27.50%
- Change of Director's Interest Notice 20 Nov 2020 1:17PM $1.160 $1.530 risen by 31.90%
- Becoming a substantial holder from CBA 2 Nov 2020 2:16PM $1.080 $1.530 risen by 41.67%
- Initial Director's Interest Notice 26 Oct 2020 10:27AM $1.090 $1.530 risen by 40.37%

101 - 125 of 477 results

Page 5 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.